A 16-year-old female came with ratol poisoning. What should we, how should we investigate further and what should be the further management?

Reading File
Finding Sources
Finding Sources
Searching PubMed

aluminium phosphide poisoning management

Finding Sources
Finding Sources
Reading Article
Searching the Web

aluminium phosphide ratol poisoning management protocol investigation 2024

Finding Sources
Reading Article
Reading Web Page

aluminium phosphide poisoning investigation management treatment protocol

I now have comprehensive information to deliver a thorough clinical answer. Here is the full structured response:

Ratol (Aluminium Phosphide) Poisoning - Clinical Management

What is Ratol?

"Ratol" is the common street name for aluminium phosphide (AlP) tablets used as a rodenticide/grain fumigant, widely available in South Asia. When ingested, AlP reacts with gastric acid and moisture to release phosphine gas (PH₃), a potent mitochondrial poison that inhibits cytochrome c oxidase, disrupts oxidative phosphorylation, and causes profound multi-organ failure.
Key facts:
  • Lethal dose: 150-500 mg for adults (1 tablet = ~3 g AlP)
  • Mortality: ~54% even with treatment (pooled data from 3449 Indian patients, Kumar et al., 2025)
  • Intentional ingestion accounts for ~94% of cases
  • There is no specific antidote

Step 1: Immediate Assessment and Resuscitation (CAB First)

On Arrival - Do These Simultaneously:

  1. Remove from source - take patient to fresh air/well-ventilated area; phosphine is absorbed cutaneously too
  2. Skin decontamination - remove clothes, wash skin with soap and water
  3. Airway - secure with endotracheal intubation if GCS is reduced or respiratory distress is present; prevent aspiration pneumonitis
  4. Breathing - high-flow supplemental oxygen; prepare for mechanical ventilation
  5. Circulation - establish central venous access (peripheral IV is acceptable initially); give 0.9% normal saline bolus for hypotension; start vasopressors (norepinephrine/dopamine) early - hypotension is severe and refractory
  6. Do NOT induce vomiting - this increases phosphine gas inhalation risk
  7. Do NOT give milk or alkaline solutions orally before confirming gastric decontamination plan

Step 2: Investigations

Run these urgently and simultaneously:
InvestigationWhy
ECG (continuous monitoring)Arrhythmias are common: ST changes, VT, VF, complete heart block
EchocardiographyDetects early myocardial depression/cardiogenic shock
Arterial Blood Gas (ABG)Metabolic acidosis is almost universal; guides bicarbonate therapy
Blood glucoseHyperglycemia at admission = poor prognostic marker
Serum electrolytes (Na, K, Ca, Mg)Hypomagnesemia may worsen arrhythmias; hypermagnesemia also described
Complete blood count (CBC)Assess for intravascular hemolysis
Liver function tests (LFTs)Hepatotoxicity common
Renal function tests / creatinineAcute kidney injury/renal failure
Chest X-rayAspiration pneumonitis, pulmonary edema
Serum lactateReflects tissue hypoxia / mitochondrial dysfunction
Coagulation profile (PT/INR, APTT)DIC may develop
Methemoglobin level (co-oximetry)Cyanosis not responding to O₂ suggests methemoglobinemia
Serum amylase/lipasePancreatitis
Confirmatory test for AlP (forensic/if uncertain):
  • Filter paper moistened with silver nitrate turns black in the presence of phosphine
  • Add a drop of ammonium molybdate - paper turns blue (confirmation)
  • Gold standard: gas chromatography with nitrogen-phosphorous detector on gastric content/viscera

Step 3: Gastrointestinal Decontamination

Act within 6 hours of ingestion if possible.
  • Gastric lavage with coconut oil or liquid paraffin (50-100 mL): Oil inhibits phosphine release from AlP tablets - this is a key intervention. Coconut oil has the strongest evidence (Shadnia et al.; Hafez et al. meta-analysis 2024)
  • After oil lavage, perform standard water/saline lavage
  • Sodium bicarbonate (SBC) added to lavage fluid may further reduce phosphine liberation
  • Activated charcoal (1 g/kg): has limited efficacy for AlP but can be tried if patient is alert and not vomiting; dose - child: 25-50 g
  • Do NOT use cathartics routinely

Step 4: Specific/Adjunctive Treatments

Antioxidants (reduce oxidative stress - key mechanism of toxicity):

DrugDoseEvidence
N-acetylcysteine (NAC)IV: 150 mg/kg loading, then 50 mg/kg over 4h, then 100 mg/kg over 16hRCT showed reduced mortality, ICU stay, intubation need
Vitamin E400 mg IM or oral, 8-hourlyClinical trial data - reduces mortality
GlutathioneIV infusionExperimental; used in some centers

Cardiovascular Support:

  • Vasopressors: Norepinephrine first-line for refractory hypotension
  • Inotropes: Dobutamine for cardiogenic shock component
  • Glucose-Insulin-Potassium (GIK) infusion: Has shown mortality benefit in clinical studies - acts as metabolic cardioprotection
  • Digoxin + Glucagon combination: Reported as beneficial in some case series (for refractory hemodynamic compromise)
  • ECMO (Extracorporeal Membrane Oxygenation): Consider early in centers with availability - has shown survival benefit in severe cases (systematic review PMID 37387512)
  • Magnesium sulfate: IV infusion - membrane stabilization, anti-arrhythmic, antioxidant. Evidence mixed; check Mg levels first to avoid hypermagnesemia

Metabolic/Acid-Base:

  • IV Sodium bicarbonate: For metabolic acidosis - "aggressive acidosis correction" protocol significantly improved outcomes (30% vs 55% mortality reduction in one study)
  • Insulin (for stress hyperglycemia): Target glucose <180 mg/dL

Renal Replacement:

  • Hemodialysis/peritoneal dialysis: Not effective for removing phosphine itself, but indicated for renal failure, severe acidosis, or fluid overload
  • Peritoneal dialysis has been used successfully in cases with severe metabolic acidosis

Methemoglobinemia (if present):

  • Methylene blue 1% solution: 2 mg/kg IV over 5 minutes - can repeat if cyanosis persists

Step 5: Monitoring in ICU

  • Continuous cardiac monitoring - fatal arrhythmias can occur at any time in first 24-48 hours
  • Serial ABGs every 2-4 hours
  • Hourly urine output
  • Serial echocardiography for cardiac function
  • Blood glucose every 2-4 hours

Step 6: Prognostic Markers (Poor Prognosis)

  • Severe hypotension at admission (most common presentation: ~78% of patients)
  • Severe metabolic acidosis (pH <7.1)
  • Hyperglycemia at admission
  • Large ingested dose (>1.5 g - though survivors reported even at 9 g)
  • Delayed presentation (>6 hours)
  • Refractory arrhythmias

Step 7: Since This is a 16-Year-Old Female

Given the patient's age and that ~94% of AlP poisonings are intentional (suicidal), mandatory psychiatric evaluation is needed once medically stable. Assess for:
  • Depression and suicidal ideation
  • Underlying psychosocial stressors
  • Family dynamics and safety at home
  • Arrange follow-up with adolescent psychiatry before discharge

Summary Algorithm

Arrival → CAB Resuscitation
         ↓
Remove from exposure + Skin decontamination
         ↓
Urgent investigations (ECG, ABG, electrolytes, glucose, LFTs, RFTs, CBC)
         ↓
Gastric lavage with coconut oil/liquid paraffin (within 6 hours)
         ↓
Vasopressors + Inotropes for hemodynamic support
         ↓
NAC + Vitamin E (antioxidants)
         ↓
IV Sodium bicarbonate for metabolic acidosis
         ↓
GIK infusion + Magnesium sulfate (check levels)
         ↓
ICU admission - continuous cardiac monitoring
         ↓
Dialysis if renal failure/severe acidosis
         ↓
ECMO if refractory cardiorespiratory failure
         ↓
Medical stabilization → Psychiatric evaluation

Important note: There is no proven antidote for AlP/Ratol poisoning. Management is entirely supportive. Despite aggressive therapy, mortality remains ~50%. Early presentation, aggressive resuscitation, oil-based gastric lavage, and antioxidant therapy offer the best chance of survival (Sobh et al., Crit Rev Toxicol 2023 [PMID 37387512]).
This is a shared conversation. Sign in to Orris to start your own chat.